Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03693144 · ClinicalTrials.gov registry record · NA

Improving Nutritional Choices in Adolescents

A NA study of Overweight and Obesity, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
19
Enrollment target
1
Study location

NCT03693144: Completed NA study of Overweight and Obesity, sponsored by University of Michigan.

NCT03693144 is a NA study of Overweight and Obesity that has completed, run by University of Michigan. The registered enrollment target is 19 participants, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03693144, a NA study of Overweight and Obesity, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
19 participants
Enrollment target
1
Study location

Study Summary

The goal of this project is to test whether the mobile application helps Black adolescents make healthy food choices at the point of purchase.

Primary Outcome

Change in number of weekly visits to Fast Food Restaurants

Conditions Studied

Interventions

  • OTHER Full LIITA3H App
  • OTHER Partial LIITA3H App
  • OTHER LIITA3H Location only

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2019-11-25
Est. Completion 2021-05-01
Phase NA
University of Michigan

1,327 total trials

What the finished NCT03693144 record still lists

NCT03693144 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (92% lower).

The record links to 1 condition, with Overweight and Obesity appearing as the primary indexed condition, and to 3 interventions - of which Full LIITA3H App is the first listed.

NCT03693144 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT03693144 about?

NCT03693144 is a clinical study titled "Improving Nutritional Choices in Adolescents". The goal of this project is to test whether the mobile application helps Black adolescents make healthy food choices at the point of purchase.

What is the current status of trial NCT03693144?

This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2019-11-25. Estimated completion is 2021-05-01.

What conditions does trial NCT03693144 study?

This clinical trial studies the following conditions: Overweight and Obesity.

What interventions are being tested in trial NCT03693144?

The interventions under investigation include: Full LIITA3H App (OTHER), Partial LIITA3H App (OTHER), LIITA3H Location only (OTHER).

Who is sponsoring clinical trial NCT03693144?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03693144 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overweight and Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03693144's enrollment target sits among peer trials

19 108th of 115 higher than 8 of 115 other Overweight and Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Overweight and Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03207464 · 19 participants · Phase 1

    Molecular Imaging of NET Using [C-11]MRB-PET in MS

  • NCT04318717 · 19 participants · Phase 2

    Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma

  • NCT05103904 · 19 participants · Phase 2

    Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

  • NCT05607407 · 19 participants · Phase 2

    Methimazole in Patients With Progressive Glioblastoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03693144, the US trial registry maintained by the National Library of Medicine. NCT03693144 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.